PharmaShots Weekly Snapshot (Oct 5-9, 2020)
Published: Oct 9, 2020 | Tags: Alpha-1 Antitrypsin-Associated Liver Disease, Arrowhead, Collaborates, Commercialize. ARO-AAT, Develop, Takeda, with
Published: Oct 9, 2020 | Tags: COVID-19, Demonstrate, Incyte, Lilly, Olumiant, Recovery Time, Reduction
Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases
Published: Oct 9, 2020 | Tags: Agreement, Develop, Diagnostics, Diseases, Genentech, Imaging, Imbio, Lung, Signs
Regeneron Seeks the US FDA's EUA for REGN-COV2 Antibody Combination to Treat COVID-19
Published: Oct 9, 2020 | Tags: Approve, COVID-19, Emergency, Regeneron, REGN-COV2, Seeks, Use, USFDA
Amgen Report Mixed Results of Omecamtiv Mecarbil in P-lll GALACTIC-HF Study for Heart Failure
Published: Oct 9, 2020 | Tags: Amgen, GALACTIC-HF Study, Heart Failure, Omecamtiv Mecarbil, P-lll, Report, results
J&J to Supply EU with up to 400M Doses of its COVID-19 Vaccine
Published: Oct 9, 2020 | Tags: 200M Doses, Advance Purchase Agreement, EU, J&J, Janssen COVID-19 Vaccine, Candidate
Published: Oct 8, 2020 | Tags: BioMarin, Palynziq, pegvaliase-pqpz, Phenylketonuria (PKU), US FDA Approval
BMS Zeposia (ozanimod) Receives Health Canada Approval for Relapsing Remitting Multiple Sclerosis
Published: Oct 8, 2020 | Tags: (ozanimod), BMS, Health Canada Approval, Relapsing Remitting Multiple Sclerosis, Zeposia
Eli Lilly Seeks the US FDA's EUA for its COVID-19 Antibody Treatment
Published: Oct 8, 2020 | Tags: Antibody Treatment, COVID-19, Eli Lilly, EUA, FDA, Seeks, US
Eli Lilly Collaborates with Dexcom for Diabetes Management
Published: Oct 8, 2020 | Tags: DexCom, Diabetes, Help, Improve, Lilly, Management, New, Program, Teams
Published: Oct 8, 2020 | Tags: (129Xe) gas, hyperpolarised, Lung Imaging, NDA submission, Polarean, reports, Us FDA
Published: Oct 8, 2020 | Tags: BMS, CheckMate-816, CT, Nivolumab, Opdivo, P-III, Report, Resectable Non-Small Cell Lung Cancer, results, Trial
PhaseBio Reports First Patients Dosing in its P-III REVERSE-IT Study of Bentracimab in Canada
Published: Oct 7, 2020 | Tags: Antiplatelet Effects, Bentracimab, Dosing, Generics, PhaseBio, REVERSE-IT Study, ticagrelor
GSK Signs an Agreement with Vir Biotechnology to Develop Solutions for Coronaviruses
Published: Oct 7, 2020 | Tags: Agreement, Collaboration, Coronavirus, GSK, Immune System Stimulation, Pathogen Neutralization, vaccine, Vir Biotechnology
BioNTech and Pfizer Initiates Rolling Submission to EMA for SARS-CoV-2 Vaccine Candidate, BNT162b2
Published: Oct 7, 2020 | Tags: BioNTech, BNT162b2, Candidate, EMA, Pfizer, reports, Rolling Submission, SARS-CoV-2, vaccine
Published: Oct 7, 2020 | Tags: Ablynx, Anti-ADAMTS5 Nanobody, Merck, Novartis, Osteoarthritis, Out-Licensing Agreement
Samsung Bioepis and Biogen Announce EMA Filling Acceptance of SB11 (biosimilar, Lucentis)
Published: Oct 7, 2020 | Tags: Biogen, Biosimilar, EMA Filling, Lucentis, Ophthalmology, Samsung Bioepis, SB11
Exact Sciences and Pfizer Announce Extension and Amendment of their Cologuard Promotion Agreement
Published: Oct 7, 2020 | Tags: Agreement, Amend, Cologuard, Exact Sciences, Extend, Pfizer, Promotion, Signs
Santhera Halts P-III SIDEROS Study Evaluating Puldysa in Patients with DMD
Published: Oct 6, 2020 | Tags: Discontinue, Duchenne Muscular Dystrophy (DMD), Idebenone, Puldysa, Santhera
GSK and AstraZeneca Plan to Deploy NVIDIA's Supercomputer for Drug Development
Published: Oct 6, 2020 | Tags: AstraZeneca, Deploy, Drug Development, GSK, NVIDIA, Plan, Supercomputer
Published: Oct 6, 2020 | Tags: Amgen, CodeBreaK 100 clinical study, Investigational KRAS G12C Inhibitor, NSCLC, Sotorasib
Published: Oct 6, 2020 | Tags: Beovu, Brolucizumab, EURETINA 2020 virtual congress, HAWK and HARRIER clinical trials, Novartis, P-III, wet AMD patients
Qiagen to Launch Viral RNA Epidemiology Test for COVID-19 and Other RNA Viruses
Published: Oct 6, 2020 | Tags: Accelerates, COVID-19, Kit, Launch, Novel, PCR Analysis, Qiagen, Simplifies, Testing Portfolio
Published: Oct 6, 2020 | Tags: Agreement, Collaboration, Evaluate, Nirogacestat + PF-06863135, patients, Pfizer, Relapsed or Refractory Multiple Myeloma, Signs, SpringWorks Therapeutics
Published: Oct 6, 2020 | Tags: 1L, Advanced Ovarian Cancer, approval, GSK, Health Canada, niraparib, receives, Treatment, Women, Zejula
Novartis Reports Results of Zolgensma in P-III STR1VE-EU Study for SMA Type 1
Published: Oct 5, 2020 | Tags: Novartis, P-III STR1VE-EU Study, reports, results, Spinal Muscular Atrophy Type 1, Zolgensma
Published: Oct 5,2020 | Tags: Aimovig, Amgen, Dual Study, erenumab-aooe, P-ll, Report, Result
Published: Oct 5, 2020 | Tags: AstraZenca, Breakthrough Therapy Designation, Chronic Kidney Disease, Farxiga, US FDA's
AstraZeneca Resumes Clinical Study of its COVID-19 Vaccine in Japan
Published: Oct 5, 2020 | Tags: AstraZeneca, Clinical Study, Covid-19 Vaccine, Resumes
BMS to Acquire MyoKardia for ~$13.1B
Published: Oct 5, 2020 | Tags: ~$13.1B, Acquire, BMS, MyoKardia
STADA Expands its Specialty Footprint with the Acquisition of Lobsor Pharmaceuticals
Published: Oct 5, 2020 | Tags: Acquires, Advanced, Footprint, Innovative Therapy, Lobsor Pharmaceuticals, Parkinson's Disease, Specialty Pharmaceuticals, STADA, Strengthen, Treating
Related News: PharmaShots Weekly Snapshot (Sept 28 - Oct 1, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com